Quantitation of 7 N-Nitrosamines in Monoclonal antibody (mAb) formulations using LC-MS/MS

Posters | 2023 | Shimadzu | ASMSInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
Industries
Pharma & Biopharma
Manufacturer
Shimadzu
Go to the libraryView PDF
Downloadable PDF for viewing
 

Similar PDF

Quantitation of 7 N-nitrosamines in Monoclonal Antibody (mAb) Formulations Using LC-MS/MS
Quantitation of 7 N-nitrosamines in Monoclonal Antibody (mAb) Formulations Using LC-MS/MS
2025|Shimadzu|Applications
Simultaneous Quantitation of N-nitrosamines and NDSRI in API and Formulation by Using a DUISTM Ionization Source in LC-MS/MS
Simultaneous Quantitation of N-nitrosamines and NDSRI in API and Formulation by Using a DUISTM Ionization Source in LC-MS/MS
2025|Shimadzu|Applications
race Level Quantitation of 8 Nitrosamines Including Varenicline Nitroso-Drug Substance Related Impurity (VNDSRI) in Varenicline Tablets Using LCMS-8045
race Level Quantitation of 8 Nitrosamines Including Varenicline Nitroso-Drug Substance Related Impurity (VNDSRI) in Varenicline Tablets Using LCMS-8045
2022|Shimadzu|Applications
Simultaneous quantitation of N-nitrosamines and NDSRI in API and formulation by using a DUIS ionization source in LC-MS/MS
Simultaneous quantitation of N-nitrosamines and NDSRI in API and formulation by using a DUIS ionization source in LC-MS/MS
2024|Shimadzu|Posters